JP Patent

JP7357571B2 — 神経学的及び神経変性疾患及び障害を処置するための鼻腔投与組成物

Assigned to ラケシス・バイオサイエンシーズ・リミテッド · Expires 2023-10-06 · 3y expired

What this patent protects

Patent listed against esketamine-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP7357571B2
Jurisdiction
JP
Classification
—
Expires
2023-10-06
Drug substance claim
No
Drug product claim
No
Assignee
ラケシス・バイオサイエンシーズ・リミテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.